Renal cell carcinoma-adjacent tissues enhance mobilization and recruitment of endothelial progenitor cells to promote the invasion of the neoplasm

Biomedicine and Pharmacotherapy

Volumn 67, Issue 7, 2013, Pages 643-649

  Zhao, Yan ^a   Yu, Peng ^a   Wu, Ran ^a   Ge, Yuzheng ^a   Wu, Jianping ^a   Zhu, Jiageng ^a   Jia, Ruipeng ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Angiogenic factors; Angiogenic factors receptor; Endothelial progenitor cells; Renal cell carcinoma; Tumor adjacent tissues

Indexed keywords

ANGIOGENIC FACTOR; CD34 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; MESSENGER RNA; STROMAL CELL DERIVED FACTOR 1; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PARAMETERS; CELL POPULATION; CONTROLLED STUDY; ENDOTHELIAL PROGENITOR CELL; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; MICROVASCULAR DENSITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL MOBILIZATION; TUMOR INVASION; TUMOR VOLUME;

ANGIOGENIC FACTORS; ANGIOGENIC FACTORS RECEPTOR; ENDOTHELIAL PROGENITOR CELLS; RENAL CELL CARCINOMA; TUMOR-ADJACENT TISSUES;

ANIMALS; CARCINOMA, RENAL CELL; CELL LINE, TUMOR; CELL MOVEMENT; CHEMOKINE CXCL12; KIDNEY NEOPLASMS; MALE; MICE; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; RECEPTORS, CXCR4; STEM CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84884820334     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2013.06.009     Document Type: Article

References (34)

1. Gupta K., Miller J.D., Li J.Z., et al. Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review. Cancer Treat Rev 2008, 34(3):193-205.
2. Sacco E., Pinto F., Totaro A., et al. Imaging of renal cell carcinoma: state of the art and recent advance s. Urol Int 2011, 86(2):125-139.
3. Breau R.H., Crispen P.L., Jimenez R.E., et al. Outcome of stage T2 or greater renal cell cancer treated with partial nephrectomy. J Urol 2010, 183(5):2212-2213.
4. Barlow L.J., Korets R., Laudano M., et al. Predicting renal functional outcomes after surgery for renal cortical tumours: a multifactorial analysis. BJU Int 2010, 106(4):489-492.
5. Uzzo R.G., Novick A.C. Nephron sparing surgery for renal tumors: indications, techniques and outcomes. J Urol 2001, 166(1):6-18.
6. Kyoda Y., Kobayashi K., Hirobe M., et al. Evaluation of long-term outcome for patients with renal cell carcinoma after surgery: analysis of cancer deaths occurring more than 10years after initial treatment. Int J Clin Oncol 2013, [Epub ahead of print].
7. Liang L., Li L., Zeng J., et al. Inhibitory effect of silibinin on EGFR signal-induced renal cell carcinoma progression via suppression of the EGFR/MMP-9 signaling pathway. Oncol Rep 2012, 28(3):999-1005.
8. Wang H.Y., Zhang X.B., Wang M. Expression of matrix metalloproteinase 9 (MMP-9) and laminin-receptor in breast carcinoma and their correlation with tumor metastasis and prognosis. Ai Zheng 2003, 22(5):529-532.
9. Deryugina E.I., Quigley J.P. Matrix metalloproteinases and tumor metastasis. Cancer Metastasis 2006, 25(1):9-34.
10. Fingleton B. Matrix metalloproteinases: roles in cancer and metastasis. Front Biosci 2006, 11:479-491.
11. Rookmaaker M.B., Tolboom H., Goldschmeding R., et al. Bone-marrow-derived cells contribute to endothelial repair after thrombotic microangiopathy. Blood 2002, 99(3):1095.
12. Walter D.H., Rittig K., Bahlmann F.H., et al. Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation 2002, 105(25):3017-3024.
13. Shumiya T., Shibata R., Shimizu Y., et al. Evidence for the therapeutic potential of ex vivo expanded human endothelial progenitor cells using autologous serum. Circ J 2010, 74(5):1006-1013.
14. Gordts S.C., Van Craeyveld E., Muthuramu I., et al. Lipid lowering and HDL raising gene transfer increase endothelial progenitor cells, enhance myocardial vascularity, and improve diastolic function. PLoS One 2012, 7(10):e46849.
15. Laschke M.W., Giebels C., Nickels R.M., et al. Endothelial progenitor cells contribute to the vascularization of endometriotic lesions. Am J Pathol 2011, 178(1):442-450.
16. Schuh A., Liehn E.A., Sasse A., et al. Transplantation of endothelial progenitor cells improves neovascularization and left ventricular function after myocardial infarction in a rat model. Basic Res Cardiol 2008, 103(1):69-77.
17. Tsuchiya K., Hida K., Hida Y., et al. Adrenomedullin antagonist suppresses tumor formation in renal cell carcinoma through inhibitory effects on tumor endothelial cells and endothelial progenitor mobilization. Int J Oncol 2010, 36(6):1379-1386.
18. Gao D., Nolan D.J., Mellick A.S., et al. Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis. Science 2008, 319(5860):195-198.
19. Li C.X., Shao Y., Ng K.T., et al. FTY720 suppresses liver tumor metastasis by reducing the population of circulating endothelial progenitor cells. PLoS One 2012, 7(2):e32380.
20. Yu D., Sun X., Qiu Y., et al. Identification and clinical significance of mobilized endothelial progenitor cells in tumor vasculogenesis of hepatocellular carcinoma. Clin Cancer Res 2007, 13(13):3814-3824.
21. Yu D.C., Chen J., Sun X.T., et al. Mechanism of endothelial progenitor cell recruitment into neo-vessels in adjacent non-tumor tissues in hepatocellular carcinoma. BMC Cancer 2010, 10:435.
22. Asahara T., Murohara T., Sullivan A., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275(5302):964-967.
23. Timmermans F., Plum J., Yöder M.C., et al. Endothelial progenitor cells: identity defined?. J Cell Mol Med 2009, 13(1):87-102.
24. Lapidot T., Petit I. Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells. Exp Hematol 2002, 30(9):973-981.
25. Murayama T., Tepper O.M., Silver M., et al. Determination of bone marrow-derived endothelial progenitor cell significance in angiogenic growth factor-induced neovascularization in vivo. Exp Hematol 2002, 30(8):967-972.
26. De Falco E., Porcelli D., Torella A.R., et al. SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells. Blood 2004, 104(12):3472-3482.
27. Yamaguchi J., Kusano K.F., Masuo O., et al. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 2003, 107(9):1322-1328.
28. Ceradini D.J., Kulkarni A.R., Callaghan M.J., et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 2004, 10(8):858-864.
29. Urbich C., Aicher A., Heeschen C., et al. Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. J Mol Cell Cardiol 2005, 39(5):733-742.
30. Abe-Yoshio Y., Abe K., Miyazaki M., et al. Involvement of bone marrow-derived endothelial progenitor cells in glomerular capillary repair in Habu snake venom-induced glomerulonephritis. Virchows Arch 2008, 453(1):97-106.
31. Massot A., Navarro-Sobrino M., Penalba A., et al. Decreased levels of angiogenic growth factors in intracranial atherosclerotic disease despite severity-related increase in endothelial progenitor cell counts. Cerebrovasc Dis 2013, 35(1):81-88.
32. Rundhaug J.E. Matrix metalloproteinases and angiogenesis. J Cell Mol Med 2005, 9(2):267-285.
33. Xu S., Zhu J., Yu L., et al. Endothelial progenitor cells: current development of their paracrine factors in cardiovascular therapy. J Cardiovasc Pharmacol 2012, 59(4):387-396.
34. Thum T., Hoeber S., Froese S., et al. Age-dependent impairment of endothelial progenitor cells is corrected by growth-hormone-mediated increase of insulin-like growth-factor-1. Circ Res 2007, 100(3):434-443.